This is an annual conference focusing on the advancement of basic and clinical research using zebrafish disease models, with topics ranging from toxicology to disease modeling. The event is open to researchers, scientists, and enthusiasts involved in the field of zebrafish research, and provides a forum for sharing the latest findings in the remarkable zebrafish model and its applications in biomedical research.
Date
Apr 05, 2019 - Apr 06, 2019
The 12th Swisszebra annual meeting takes places on Friday, April 5, 2019 to Saturday, April 6, 2019 in Leukerbad, Switzerland.
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.